Malmgren Linnea, McGuigan Fiona E, Berglundh Sofia, Westman Kerstin, Christensson Anders, Åkesson Kristina
Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Nephron. 2015;130(4):245-55. doi: 10.1159/000435790. Epub 2015 Jul 15.
BACKGROUND/AIMS: Renal function deteriorates with age, but a few studies have addressed this longitudinally in elderly women. Our objective was, using 5 estimated glomerular filtration rates (eGFR)-equations, to evaluate changes in renal function and association with adverse outcomes for a decade in 75-year-old women.
Plasma creatinine was measured at ages 75 (n = 1,011), 78 (n = 827), 80 (n = 689) and 85 (n = 363). Glomerular filtration rates were estimated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI); Modification of Diet in Renal Disease (MDRD); revised Lund-Malmö (LM-rev); Berlin Initiative Study 1 (BIS1) and Cockcroft-Gault/body surface area (CG/BSA) equations. Mortality and comorbidity were investigated in women with chronic kidney disease (CKD) stage 3A and 3B-5.
Approximately, 95% of women had eGFR indicating CKD stage 2-3 and progression towards stage 3 was continuous. The women lost 22% of their eGFR during follow-up and loss accelerated between 80 and 85. Mean loss per decade was 16.6 ml/min/1.73 m(2). Women in CKD stage 3B-5 had an adjusted hazard ratio for death of 3.5 (95% CI 2.1-5.8) compared to stage 1-2 during follow-up and increased risk of diabetes, heart failure and hypertension. The CG/BSA, BIS1 and LM-rev equations continuously predicted lower eGFR than the MDRD and CKD-EPI equations.
eGFR in women aged 75-85 ranges from 30 to 89 ml/min/1.73 m(2) (stage 2-3). Decline was 16.6 ml/min/1.73 m(2) per decade; accelerated with age and appeared nonlinear. Women with CKD 3B-5 demonstrate an over 3-fold risk of death. eGFR <45 ml/min/1.73 m(2) was associated with mortality, confirming the new KDIGO classification 3A and 3B, as clinically applicable in the elderly.
背景/目的:肾功能随年龄增长而恶化,但针对老年女性进行纵向研究的较少。我们的目标是使用5种估算肾小球滤过率(eGFR)方程,评估75岁女性十年间肾功能的变化及其与不良结局的关联。
在75岁(n = 1011)、78岁(n = 827)、80岁(n = 689)和85岁(n = 363)时测量血浆肌酐。使用慢性肾脏病流行病学协作组(CKD-EPI)、肾脏病饮食改良(MDRD)、修订的隆德-马尔默(LM-rev)、柏林倡议研究1(BIS1)以及Cockcroft-Gault/体表面积(CG/BSA)方程估算肾小球滤过率。对慢性肾脏病(CKD)3A期和3B-5期的女性进行死亡率和合并症调查。
约95%的女性eGFR表明处于CKD 2-3期,且向3期的进展是持续的。随访期间女性的eGFR下降了22%,在80至85岁之间下降加速。每十年的平均下降幅度为16.6 ml/min/1.73 m²。CKD 3B-5期的女性在随访期间死亡的校正风险比为3.5(95%CI 2.1-5.8),患糖尿病、心力衰竭和高血压的风险增加。与MDRD和CKD-EPI方程相比,CG/BSA、BIS1和LM-rev方程持续预测的eGFR较低。
75至85岁女性的eGFR范围为30至89 ml/min/1.73 m²(2-3期)。每十年下降16.6 ml/min/1.73 m²;随年龄增长而加速,且呈非线性。CKD 3B-5期的女性死亡风险超过3倍。eGFR<45 ml/min/1.73 m²与死亡率相关,证实了新的KDIGO分类3A和3B在老年人中具有临床适用性。